共 210 条
[1]
Masnoon N(2017)What is polypharmacy? A systematic review of definitions BMC Geriatr 17 230-215
[2]
Shakib S(2019)Survival of the elderly and exposition to polypharmacy in the city of Sao Paulo, Brazil: SABE Study Rev Bras Epidemiol 21 e180006-746
[3]
Kalisch-Ellett L(2018)A healthy lifestyle attenuates the effect of polypharmacy on total and cardiovascular mortality: a national prospective cohort study Sci Rep 8 12615-560
[4]
Caughey GE(2013)Mortality in older care home residents in England and Wales Age Ageing 42 209-309
[5]
Romano-Lieber NS(2013)Nondisease-specific problems and all-cause mortality in the REasons for Geographic and Racial Differences in Stroke study J Am Geriatr Soc 61 739-175
[6]
Corona LP(2011)Variation over time in the association between polypharmacy and mortality in the older population Drugs Aging 28 547-1521
[7]
Marques LFG(2015)Polypharmacy in the elderly: a marker of increased risk of mortality in a population-based prospective study (NEDICES) Gerontology 61 301-220
[8]
Secoli SR(2006)Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE study J Gerontol A Biol Sci Med Sci 61 170-285
[9]
Martinez-Gomez D(2020)Assessing risks of polypharmacy involving medications with anticholinergic properties Ann Fam Med 18 148-689
[10]
Guallar-Castillon P(2017)Total anticholinergic burden and survival within a cohort of elderly Mexican Americans Geriatr Gerontol Int 17 1515-807